Andrew H. Limper mostly deals with Pneumocystis carinii, Microbiology, Lung, Respiratory disease and Immunology. The study incorporates disciplines such as Cell culture, Phagocytosis, Glycoprotein, Macrophage and Fungal protein in addition to Pneumocystis carinii. His research in Microbiology tackles topics such as Receptor which are related to areas like Inflammation, Secretion and Pulmonary alveolus.
His Lung study incorporates themes from Chemotherapy induced and Corticosteroid therapy. His Respiratory disease research is under the purview of Internal medicine. His work on Pneumovirus, Mononegavirales and Pneumovirinae as part of general Immunology study is frequently linked to AIDS-Related Opportunistic Infections, bridging the gap between disciplines.
His primary areas of study are Pneumocystis carinii, Immunology, Microbiology, Internal medicine and Lung. His work focuses on many connections between Pneumocystis carinii and other disciplines, such as Cell biology, that overlap with his field of interest in Secretion. His Immunology research is multidisciplinary, relying on both Pneumocystis pneumonia and Pneumonia.
His Microbiology research focuses on Tumor necrosis factor alpha and how it connects with Proinflammatory cytokine. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Surgery and Oncology. His Lung course of study focuses on Pathology and Idiopathic pulmonary fibrosis.
Andrew H. Limper mainly focuses on Internal medicine, Immunology, Pneumocystis pneumonia, Lung and Pulmonary fibrosis. His work is dedicated to discovering how Internal medicine, Gastroenterology are connected with Polymerase chain reaction and other disciplines. Many of his studies on Immunology involve topics that are commonly interrelated, such as Pneumonia.
He has researched Pneumocystis pneumonia in several fields, including Incidence, Pneumocystis jirovecii, Retrospective cohort study and Respiratory failure. In the field of Lung, his study on Idiopathic pulmonary fibrosis overlaps with subjects such as Viral pneumonia. Andrew H. Limper works mostly in the field of Innate immune system, limiting it down to topics relating to Pneumocystis carinii and, in certain cases, Cell biology.
Andrew H. Limper mostly deals with Internal medicine, Immunology, Lung, Respiratory system and Cancer research. His Immunology research incorporates elements of Oxidative stress and Pneumonia. His study looks at the intersection of Pneumonia and topics like Receiver operating characteristic with Bronchoalveolar lavage.
His study looks at the relationship between Lung and fields such as Inflammation, as well as how they intersect with chemical problems. His work deals with themes such as Pneumocystis pneumonia, Mechanical ventilation, Retrospective cohort study and Respiratory failure, which intersect with Respiratory system. His Cancer research research integrates issues from Transcriptome, Lung cancer and COPD.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Medical progress: Pneumocystis pneumonia
Charles F. Thomas;Andrew H. Limper.
The New England Journal of Medicine (2004)
Imatinib mesylate inhibits the profibrogenic activity of TGF-β and prevents bleomycin-mediated lung fibrosis
Craig E. Daniels;Mark C. Wilkes;Maryanne Edens;Ted J. Kottom.
Journal of Clinical Investigation (2004)
Pneumocystis carinii Pneumonia in Patients Without Acquired Immunodeficiency Syndrome: Associated Illnesses and Prior Corticosteroid Therapy
Steven H. Yale;Andrew H. Limper.
Mayo Clinic Proceedings (1996)
An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients
Andrew H. Limper;Kenneth S. Knox;George A. Sarosi;Neil M. Ampel.
American Journal of Respiratory and Critical Care Medicine (2011)
Pneumocystis carinii Pneumonia: Differences in Lung Parasite Number and Inflammation in Patients with and without AIDS
Andrew H. Limper;Kenneth P. Offord;Thomas F. Smith;William J. Martin.
The American review of respiratory disease (1989)
Pulmonary Langerhans'-cell histiocytosis.
Robert Vassallo;Jay H. Ryu;Thomas V. Colby;Thomas Hartman.
The New England Journal of Medicine (2000)
Tracheobronchial Foreign Bodies in Adults
Andrew H. Limper;Udaya B. S. Prakash.
Annals of Internal Medicine (1990)
Stretch induces cytokine release by alveolar epithelial cells in vitro.
Nicholas E. Vlahakis;Mark A. Schroeder;Andrew H. Limper;Rolf D. Hubmayr.
American Journal of Physiology-lung Cellular and Molecular Physiology (1999)
Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults.
Robert Vassallo;Jay H. Ryu;Darrell R. Schroeder;Paul A. Decker.
The New England Journal of Medicine (2002)
Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results.
Craig E. Daniels;Joseph A. Lasky;Andrew H. Limper;Kathleen Mieras.
American Journal of Respiratory and Critical Care Medicine (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Mayo Clinic
Mayo Clinic
Cornell University
Mayo Clinic
Mayo Clinic
Mayo Clinic
University of Colorado Denver
University of Pittsburgh
Mayo Clinic
University of Michigan–Ann Arbor
Iowa State University
Weierstrass Institute for Applied Analysis and Stochastics
National Institute of Advanced Industrial Science and Technology
Forschungszentrum Jülich
Sogang University
University of Montreal
University of Copenhagen
University of Queensland
University of Maryland Center For Environmental Sciences
Ghent University
Utrecht University
University of Novi Sad
Seoul National University
University of Sydney
University of Washington
University of Oxford